Track Santen Pharmaceutical , Ltd.'s intangible assets ($70B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Santen Pharmaceutical , Ltd. (SNPHY) currently reports a intangible assets of $70B as of September 2026. That compares with $78B in the prior-year period — down 10.3% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s intangible assets history and peer comparisons.
Santen Pharmaceutical , Ltd.'s intangible assets decreased from $78B to $70B — a 10.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Santen Pharmaceutical , Ltd. reported $70B in intangible assets as of September 2026. That compares with $78B in the prior-year period — down 10.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current intangible assets of $70B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHY for alerts when major investors trade the stock.